Benefits
TRIBUTIN is available as coated, gastro-resistant, controlled-release tablets.
The pharmaceutical technology that has been used for the form of controlled release has been studied in such a way as to lead the three active ingredients (butyric acid, fructo-oligosaccharides and bifidobacteria) directly to the large intestine, where they can act effectively, contributing to the maintenance of good condition of the epithelial cells of the colon, enhancing the cell cycle of the intestinal epithelium and promoting the normalization of bowel movements with a subsequent reduction of painful symptoms caused by the colon.
Its composition is protected by an Italian (No. 0001395328) and European (No. 2289505) patent.